Skip to main content
. 2018 Oct 16;19(10):3198. doi: 10.3390/ijms19103198
aa Amino acid
alloHSCT Allogeneic hematopoietic stem cell transplant
AML Acute myeloid leukemia
CK-AML Complex karyotype AML
CML Chronic myeloid leukemia
CN Cytogenetically normal
CR Complete remission
Del Deletion
DFS Disease-free survival
EFS Event-free survival
FLT3 FMS-like tyrosine kinase 3
FLT3L FLT3 ligand
FLT3-mut FLT3 mutation
HSC Hematopoietic stem/progenitor cell
IL-3 Interleukin-3
Indels Small insertions or deletions
ITD Internal tandem duplication
LI-C Leukemia-inducing cells
LSCs Leukemic stem cells
MDS Myelodysplastic syndrome
MLL-PTD MLL-partial tandem duplication
MRD Minimal residual disease
OS Overall survival
PDGF Platelet-derived growth factor
PR Partial remission
RFS Relapse-free survival
RTK Receptor tyrosine kinase
TK Tyrosine kinase
TKD Tyrosine kinase domain
TKIs Tyrosine kinase inhibitors